Image

Auditory Diagnostics and Error-based Treatment

Auditory Diagnostics and Error-based Treatment

Non Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The main objective of this study is to assess the effectiveness of an integrated program of fitting and training interventions aimed at reducing unexpected variability and addressing the specific error patterns of each recipient.

The participants will undergo 1 visit lasting approximately 2 hours at the Radboud university medical center's ENT department, where they will undergo a series of diagnostic tests. Some of the participants will also be asked to self-administer additional tests using a Windows tablet.

Based on the outcomes of speech recognition tests in quiet at the first visit, the participants will be called for follow-up interventions concerning both the fitting of their CI and personalized auditory training based on their personal error patterns. These interventions will take place over the course of approximately 5 months and will be made up of three follow-up visits and a period of self-administered training through a mobile application on a tablet.

One final follow-up visit will check whether any changes from the interventions are retained after four weeks.

Eligibility

Inclusion Criteria:

  • Adult (over 18 years old at the time of inclusion )
  • Post-lingually deafened (the subject had a good mastery of spoken language before onset of deafness)
  • Native Dutch speaker
  • Implanted, either unilaterally or bilaterally, with a Cochlear Implant manufactured by Cochlear Ltd (i.e., a Nucleus ® implant).
  • Implanted with one of the following implants: CI422, CI512, CI522, CI532, CI24M, CI24R, CI24RE.
  • Implanted for at least 12 months.

Exclusion Criteria:

  • Known abnormally formed cochlea
  • Known pre-implantation ossification of the cochlea
  • Severe cognitive disorders affecting their ability to understand spoken language
  • Intense facial nerve stimulation
  • Unaddressed electrode tip foldover
  • More than 4 electrodes deactivated because of malfunction (open/short circuit) or lack of response
  • Additional illnesses or handicaps that could impact ability to participate in study, at the clinician's discretion.

Study details
    Deafness
    Bilateral
    Deafness Neurosensory
    Deafness Permanent

NCT05307952

Radboud University Medical Center

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.